Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
BonitaSoft Raises $13M in Series C Funding
-
Gamida Cell Reports StemEx® Phase II/III Study Safety and Efficacy Data
-
SuperSonic Imagine : SuperSonic Imagine Announces a Significant Financing Round -- 28 Million Euros Raised -- FSI Subscribes to Half the Round Alongside Historical Investors and Two New Arrivals
-
Auriga Reiterates a 'Buy' on Patterson Companies (PDCO); Revenue Growth from All Segments
-
Auriga Reiterates a 'Buy' on Thermo Fisher Scientific (TMO); Takeaways From Analyst Day
-
Auriga Maintains a 'Buy' on Trina Solar (TSL); Trying To Add Things Up
-
Auriga Maintains a 'Hold' on Suntech Power (STP); Survival Economics at Play
-
Auriga Maintains a 'Buy' on Herbalife (HLF); Spark From Additional Licenses in China
-
Auriga Cuts PT and Estimates on HEICO (HEI); Cautious on Decelerating FSG Growth
-
Auriga Reiterates a 'Buy' on DSW Inc. (DSW); Raising Estimates and PT After Great Q1
-
UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
-
UPDATE: Auriga Upgrades Lifepoint Holdings (LPNT) to Buy; Use Recent Pullback As Opportunity
-
UPDATE: Auriga Starts Akorn (AKRX) at Buy; Unique Product Portfolio with Limited Competition
-
Notable Analyst Rating Changes 05/23: (SBUX) (AMAT) (WMB) Upgraded; (NDAQ) (PSO) (ARBA) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 05/22: (FMCN) (RF) (FB) (JPM) (CHK) (DRYS)
-
Auriga Maintains a 'Buy' on Myriad Genetics (MYGN); Understanding Two Areas of Concern
-
Auriga Maintains a 'Buy' on Spirit AeroSystems (SPR); Immune from Broader Defense Worries
-
Auriga Reiterates a 'Buy' on Steven Madden (SHOO); Positive Take-aways From CEO Meeting
-
Auriga Maintains a 'Buy' on DSW Inc. (DSW); Guidance and Dividend Raised on Strong Q1
-
Streetinsider.com's Hot Lunchtime Reads 05/18: (FB) (MA) (SQNM) (CVH) (JPM)
-
Auriga Securities on Sequenom (SQNM): Coventry (CVH) Giveth, Coventry Taketh Away
-
Auriga Reiterates a 'Buy' on Quality Systems (QSII); Q4 Meets Reduced Expectations; Accumulate on Weakness
-
Auriga Reiterates a 'Buy' on Aruba Networks (ARUN); Strength of Underlying Fundamentals
-
Auriga Maintains a 'Hold' on Schnitzer Steel (SCHN); Cutting Estimates on Lowered Outlook
-
Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); Generic Leucovorin Shortage Continues
-
Auriga Reiterates a 'Buy' on Ubiquiti Networks (UBNT); Trends Remain Robust
-
Auriga Reiterates a 'Buy' on Herbalife (HLF); Shares Still Offer Material Upside
-
Auriga Maintains a 'Buy' on Patterson Companies (PDCO); Q4 Preview
-
Auriga on Solar Power/CleanTech: Solar Photovoltaics: US - China Solar Trade Investigation; Upcoming Catalysts
-
Auriga Upgrades Quality Systems (QSII) to Buy; Pre-Announcement Presents Opportunity
-
Auriga Maintains a 'Buy' on Globe Specialty Metals (GSM); In-line Results; Pricing Still An Issue
-
Auriga Reiterates a 'Buy' on Impax Laboratories (IPXL); Positive After Meetin with Management
-
Auriga Reiterates a 'Buy' on DSW Inc. (DSW); Channel Checks Solid
-
UPDATE: Auriga Downgrades Dole (DOLE) to Hold; Valuation Call
-
Auriga on Canadian Solar (CSIQ); Traction on Shipments, Costs, EPC Visibility Offset by Sharp ASP Erosion
-
Auriga Maintains a 'Hold' on Heartware Int'l (HTWR); Impressive Growth in Europe
-
Compass Point Reiterates a 'Buy' on Howard Hughes Corp (HHC); Raising PT After Solid Quarter
-
Auriga Reiterates a 'Buy' on Medicis (MRX); Q1 Beat Underscores Execution
-
Auriga Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Eyes on Elelyso launch in U.S.
-
Auriga Maintains a 'Buy' on MEMC Electronic Materials (WFR); Valuation the Real Issue
-
Streetinsider.com's Hot Lunchtime Reads 05/09: (S) (kkd) (WEN) (GLD) (TPX) (HLF)
-
Auriga Maintains a 'Hold' on ADTRAN (ADTN); NSN Deal Closes
-
Auriga Reiterates a 'Buy' on CPI Aerostructures (CVU); Transformational Bids in the Pipeline
-
Auriga Maintains 'Buy' on Herbalife (HLF); Takeaways From Analyst Meeting
-
Auriga Reiterates a 'Buy' on Medifast (MED); Still Like Long-Term, But Cutting Estimates on Mixed Results
-
Auriga Downgrades Chiquita (CQB) to Hold; Cutting Estimates on Tough Conditions
-
Auriga Maintains a 'Buy' on Perrigo Co. (PRGO); Accumulate Shares on Weakness
-
Auriga Maintains a 'Hold' on Henry Schein (HSIC); Solid Q1, But Lack of Visibility Keeps Us Sidelined
-
Auriga Maintains a 'Hold' on Heartware Int'l (HTWR); Enrollment Completed for ENDURANCE Trial
-
Auriga Reiterates a 'Buy' on Jazz Pharmaceuticals (JAZZ); Lifting Numbers on 'Beat & Raise'
